R&D

In July 2021, Angel pharma launched two R&D centers in China and the United States, located in Jiaxing, China and San Francisco, the United States respectively. Relying on the dual R&D centers in China and the US, Angel Pharmaceutical has established a China-US innovative drug research and development team, which includes the whole process of innovative drug early research and development, animal experiment, pharmacodynamic safety evaluation, IND application and clinical trial.

The R&D center of Jiaxing HQ covers more than 3000 square meters, with perfect biological and chemical innovative drug research and development laboratories and drug analysis equipments, which will greatly accelerate the expansion of pharmaceutical innovation pipeline in the future.

The San Francisco R&D center covers more than 1000 square meters, and has perfect small molecule drug synthesis and analysis equipments.